According to the Zhitong Finance App, Weijun Biotechnology (00660) announced that the company and the petitioner had reached a settlement on the petition on November 28, 2023, and neither party acknowledged any responsibility (settlement). Following a settlement, a consent summons to withdraw the petition was signed and submitted to the High Court of Hong Kong on December 4, 2023. Subsequently, the Hong Kong High Court issued a petition on December 6, 2023, which was withdrawn.